The doctor appealed the hospital's decision in hopes of returning to work, but that appeal was ultimately denied. 

The self-expandable device was designed to treat “no-option” chest pain patients who see no long-term benefits from other interventions. 

Researchers explored the costs associated with CABG at more than 500 U.S. hospitals. 

Carrie Redick, an ICU nurse for nearly 20 years, said understanding more about financial data improved her ability to acquire funding and other resources for her program when necessary. 

The company officially launched its Cleerly ISCHEMIA software for delivering noninvasive evaluations of CCTA exams in early 2024. This update provides a closer look at the software from a billing perspective. 

Ismail El-Hamamsy, MD, PhD, said he hopes to spend his time as HVS president focused on fostering collaborations and encouraging innovation.

The veteran cardiologist had been worried that cerebral protection devices were only being used to treat TAVR patients with specific insurance plans. The lawsuit has now been resolved to the “mutual satisfaction” of both parties.

Any devices that claim to make blood glucose measurements without piercing the user's skin are associated with a heightened risk of error, the agency said.